New York City, NY -- (SBWIRE) -- 12/18/2013 -- StockMarketIntel.com issues a special report on the following stocks: iPass Inc. (NASDAQ:IPAS), NewLead Holdings Ltd (NASDAQ:NEWL), BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX), Depomed Inc (NASDAQ:DEPO)
iPass Inc. (NASDAQ:IPAS) gained 7.70% recently, while trading on 262,690 shares at the price of $1.54. If we look at its trading history of the past 52 weeks, the share price suffered a low of $1.29 and was moved to its maximum level of $2.37.The stock changed hands in a range of $1.51 to $1.60, bringing its market capitalization at about $99.04 million. iPass Inc. provides cloud-based mobility management and network connectivity services to enterprises and telecommunication carriers worldwide. Its Mobility Services segment offers network mobility services for enterprises? to manage their mobility economics, high speed network connectivity requirements, and proliferation of mobile devices; network services, such as access to commercial Wi-Fi hotspots across Wi-Fi venues for enterprise and carrier customers; and platform services, including a cloud-based Open Mobile Platform that enables enterprise users to connect from various mobile devices over a range of networks.
Why Should Investors Buy IPAS After The Recent Gain? Just Go Here and Find Out
NewLead Holdings Ltd (NASDAQ:NEWL) added 1.72% recently, in the current trading session, at $1.18 with a total volume of 35,543 shares. The stock, on average, trades on a volume of 263,214 shares. In the past 52 weeks, the share price has not declined below $1.14 and above $122.85.It floated in a range of $1.16 to $1.24 during the recent trading session, with a beta value of 1.04.Its market capitalization now moved to about $10.41 million. NewLead Holdings Ltd., a shipping and commodity company, is engaged in the transportation of refined products and dry bulk goods worldwide. The company transports various products, including gasoline, jet fuel, iron ore, coal, and grains.
What was the Moving Force behind NEWL on Bullish Run? Read This Research Report
BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) recently recorded a gain of 4.32% and was moving within a range of $6.69-$7.15. Its current trading price is $6.73. The share price hit its 52-week low of $1.12 and $7.80 was the best price. The stock completed the day with a total volume of 921,915 shares, versus an average volume of 837,143 shares. BioCryst Pharmaceuticals, Inc., a biotechnology company, designs, optimizes, and develops novel drugs that block key enzymes involved in the pathogenesis of diseases. The company integrates the disciplines of biology, crystallography, medicinal chemistry, and computer modeling to discover and develop small molecule pharmaceuticals through the structure-guided drug design process.
For How Long BCRX will fight for Profitability? Read This Trend Analysis report
Depomed Inc (NASDAQ:DEPO) added 11.54% in its current trading activity, bringing its market capitalization around $530.73 million. The total number of shares that changed hands during the current session up till now was 909,716 shares, as compared to average trading volume of 480,754shares. The share price after opening at $8.83 made a high of $9.40 and hovered above $8.72, while its recent trading price was $9.27. Depomed, Inc., a specialty pharmaceutical company, focuses on developing products for pain and other conditions, and diseases of the central nervous system in the United States.
For How Long DEPO Gloss will Attract Investors? Find out via this report
Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our site, or joining our email list.
Neither StockMarketIntel.com, nor its employees and affiliates are registered as investment advisors or broker/dealers in any jurisdiction whatsoever. Through use of this website viewing or using you agree to hold StockMarketIntel.com, its operators, owners, employees, and affiliates harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. The information contained herein is based on sources that we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. Readers should always do their own due diligence and consult a financial professional. StockMarketIntel.com encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and StockMarketIntel.com makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled company. Any opinions expressed on this website are statements of judgment as of the date of publication and are subject to change without further notice, and may not necessarily be reprinted in future publications or elsewhere.
Read Full disclaimer at: http://stockmarketintel.com/Disclaimer.htm
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)